amodiaquine has been researched along with nelfinavir in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Cook, SE; Huang, V; Murphy, BG; Olsen, M; Pedersen, N | 1 |
| Aas, PA; Afset, JE; Biza, S; Bjørås, M; Erlandsen, SE; Fenstad, MH; Hagen, L; Ianevski, A; Kainov, DE; Landsem, VM; Lysvand, H; Løseth, K; Malmring, JF; Nordbø, SA; Oksenych, V; Pettersen, CH; Reisberg, T; Tenson, T; Yao, R; Zusinaite, E | 1 |
1 review(s) available for amodiaquine and nelfinavir
| Article | Year |
|---|---|
Recent update on anti-dengue drug discovery.
Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication | 2019 |
3 other study(ies) available for amodiaquine and nelfinavir
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Perspectives: potential therapeutic options for SARS-CoV-2 patients based on feline infectious peritonitis strategies: central nervous system invasion and drug coverage.
Topics: Adenosine Triphosphate; Amodiaquine; Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; Betacoronavirus; Cats; Central Nervous System; Coronavirus Infections; Coronavirus, Feline; COVID-19; COVID-19 Drug Treatment; Feline Infectious Peritonitis; Humans; Nelfinavir; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protease Inhibitors; Pyrrolidines; SARS-CoV-2; Sulfonic Acids | 2020 |
Potential Antiviral Options against SARS-CoV-2 Infection.
Topics: Amodiaquine; Animals; Antiviral Agents; Betacoronavirus; Caco-2 Cells; Cell Line, Tumor; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Therapy, Combination; Emetine; HEK293 Cells; Homoharringtonine; HT29 Cells; Humans; Immune Sera; Immunization, Passive; Indoles; Nelfinavir; Neutralization Tests; Pandemics; Pneumonia, Viral; Pyrans; Pyrroles; SARS-CoV-2; Vero Cells | 2020 |